A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2023 Innovation Development (output) data fields PRMS | |||||||||||||||||||||||||
2 | ||||||||||||||||||||||||||
3 | Disclaimer: This spreadsheet was developed to support Innovation Development reporting in the CGIAR PRMS system. The below form does not support Theory of Change mapping. Additional guidance is provided through the Initiative 2023 Technical Report Guidance Document. There may be minor differences between data collected in this spreadsheet, and the way and order of how innovation development is reported in the CGIAR PRMS system. | |||||||||||||||||||||||||
4 | ||||||||||||||||||||||||||
5 | * are mandatory fields | |||||||||||||||||||||||||
6 | Additional 2023 innovation development data fields (information that was not collected in 2022) | |||||||||||||||||||||||||
7 | ||||||||||||||||||||||||||
8 | ||||||||||||||||||||||||||
9 | # | Section/ data collected (* are mandatory) | Response | Guidance | Additional Reference materials | |||||||||||||||||||||
10 | 0. Deciding "What you want to report?" (Initiative Output) and Result Type (Innovation Development) | |||||||||||||||||||||||||
11 | Report for: Select the CGIAR Initiative that will lead the development and/or scaling of this innovation * | *Only one possible answer – in case several Initiatives are working jointly on this innovation, please select one as the lead, and list the others in the next question *Use the search option to narrow down on your option | CGIAR Initiatives | |||||||||||||||||||||||
12 | What you want to report? * >Initiative Output >Result Type: Innovation Development | Initiative Output; Innovation development | ||||||||||||||||||||||||
13 | Are you reporting a new innovation, or updating an already existing innovation profile? * | New/ existing | ||||||||||||||||||||||||
14 | If new | Provide input on all of the below sections and data fields | ||||||||||||||||||||||||
15 | If existing | (Please indicate whether the innovation is active and receives investment by the Lead and/or Contributing Initiative(s) * | *Innovation is active and receives investment by Lead and/or Contributing Initiative(s) -> (continue to Section 1 and validate or update previously reported data + provide input on new data fields (highlighted orange) *Innovation is inactive and does not receive investment by Lead and/or Contributing Initiative(s) -> Answer next question after which no further action is needed | *Can select only on of the two options | ||||||||||||||||||||||
16 | If existing but inactive | What are the main reasons why this Innovation is inactive and does not receive investment by Lead and/or Contributing Initiative(s)? * | *No or limited progress in improving the readiness of the innovation *The innovation lead and/or team took up new responsibilities *Limited Initiative resource availability required deprioritization of the innovation *Limited bilateral co-investment required deprioritization of the innovation *Absence of strong demand and/or scaling partners for the innovation *Other (please specify): | *Can choose multiple *No further action is needed | ||||||||||||||||||||||
17 | 1. General information | |||||||||||||||||||||||||
18 | Title: Provide a long title for the innovation (30 words) * | *Try to think of a long title that clearly explains "what it is", "what it does" and "for whom" *Avoid abbreviations or (technical) jargon. * Varieties or breeds should be described by their generic traits or characteristics (e.g. Drought tolerant and aphid resistant groundnut cultivars). The specific number of new or improved lines/ varieties can be specified in Section 2 of the survey. | ||||||||||||||||||||||||
19 | Description: Provide a more detailed description of the innovation (max 150 words) * | *Provide a more detailed description explains "what it is", "what it does" and "for whom" *Avoid abbreviations or (technical) jargon. Try to explain in clear language what kind of challenge this innovation addresses/ what kind of solution it offers *Varieties or breeds should be described by their generic traits or characteristics (e.g. Drought tolerant and aphid resistant groundnut cultivars). The specific number of new or improved lines/ varieties can be specified in Section 2 of the survey. | ||||||||||||||||||||||||
20 | Lead contact person: * | *Provide the name of the contact person for this innovation | ||||||||||||||||||||||||
21 | Gender equality tag guidance* 0 = not targeted - The activity has been screened against the marker but has not been found to target gender equality. 1 = significant - Significant Gender equality is an important and deliberate objective, but not the principal reason for undertaking the activity. 2 = principal - Gender equality is the main objective of the activity and is fundamental in its design and expected results. The activity would not have been undertaken without this gender equality objective. | *When a tag of 2 is selected, evidence/explanation must be provided. *Evidence should clearly demonstrate that gender/ climate/ nutrition/ environment/ poverty are the main objective of the result and were fundamental in the design of the activity. *Evidence should preferably refer to specific performance indicators and analysis. Evidence where results are only disaggregated by - for example - gender is not sufficient. *Evidence is not required for tags 0 or 1. | https://www.oecd.org/development/gender-development/Handbook-OECD-DAC-Gender-Equality-Policy-Marker.pdf | |||||||||||||||||||||||
22 | Climate change tag guidance* 0 = not targeted - The activity does not target the climate mitigation, adaptation and climate policy objectives of CGIAR as put forward in its strategy. 1 = significant - The activity contributes in a significant way to any of the three CGIAR climate-related strategy objectives – namely, climate mitigation, climate adaptation and climate policy, even though it is not the principal focus of the activity. 2 = principal - The activity is principally about meeting any of the three CGIAR climate-related strategy objectives – namely, climate mitigation, climate adaptation and climate policy, and would not have been undertaken without this objective. | There are three main climate indicators at systems level: - Turn agriculture and forest systems into a net sink for carbon by 2050 (climate mitigation target) - Equip 500 million small-scale producers to be more resilient by 2030 (climate adaptation target) - Support countries in implementing NAPs and NDCs, and increased ambition in climate actions by 2030 (climate policy target) | ||||||||||||||||||||||||
23 | Nutrition, health and food security tag guidance* 0 = not targeted - The activity has been screened against the marker but has not been found to target any aspects of nutrition, health and food security. 1 = significant - The activity has significant contribution to the above-described aspects of nutrition, health and food security, but not the principal reason for undertaking the activity. 2 = principal - The activity is principally meeting any aspects of nutrition, health and food security, and this is fundamental in its design and expected results. The activity would not have been undertaken, without this objective. | |||||||||||||||||||||||||
24 | Environmental health and biodiversity tag guidance* 0 = not targeted - The activity has been screened against the marker, but it has not been found to target any aspects of environmental health and biodiversity. 1 = significant - The activity has significant contribution to aspects of environmental health and biodiversity, but not the principal reason of undertaking the activity. 2 = principal - The activity is principally meeting any aspects of environmental health and biodiversity, and this is fundamental in its design and expected results. | There are five environmental targets and one biodiversity target in the Environmental Health and Biodiversity Impact Area: Stay within planetary and regional environmental boundaries: consumptive water use in food production of less than 2,500 km³ per year (with a focus on the most stressed basins), zero net deforestation, nitrogen application of 90 Tg per year (with a redistribution towards low-input farming systems) and increased use efficiency; and phosphorus application of 10 Tg per year. Maintain the genetic diversity of seed varieties, cultivated plants and farmed and domesticated animals and their related wild species, including through soundly managed genebanks at the national, regional, and international levels. In addition, water conservation and management, restoration of degraded lands/soils, restoration of biodiversity in situ, and management of pollution related to food systems are key areas of environmental impacts CGIAR to which the CGIAR should contribute. | ||||||||||||||||||||||||
25 | Poverty reduction, livelihoods and jobs tag guidance* 0 = not targeted - The activity has been screened against the marker but has not been found to target any aspects of poverty reduction, livelihoods and jobs. 1 = significant - The activity has significant contribution to any of the aspects of poverty reduction, livelihoods and jobs, but not the principal reason for undertaking the activity. 2 = principal - The activity is principally meeting any aspects of poverty reduction, livelihoods and jobs, and this is fundamental in its design and expected results. The activity would not have been undertaken, without this objective. | There are two poverty reduction, livelihoods and jobs targets in the results framework: "Lift at least 500 million people living in rural areas above the extreme poverty line of US $1.90 per day (2011 PPP)" "Reduce by at least half the proportion of men, women and children of all ages living in poverty in all its dimensions, according to national definitions" | ||||||||||||||||||||||||
26 | Is this result featured in a Key Result Story for the Reporting year? | Yes/ No | * | |||||||||||||||||||||||
27 | Section 2: Theory of Change | |||||||||||||||||||||||||
28 | Contributing Initiatives: CGIAR Initiative(s) that will contribute to developing and/or scaling the innovation* | *Multiple Initiatives can be selected. *Select only those Initiative(s) that are expected to make a tangible contribution to the work on this innovation *Use the search option to narrow down on your choice | CGIAR Initiatives | |||||||||||||||||||||||
29 | Contributing non-pooled projects: Provide details of bilateral/ non-pooled projects that currently contribute to developing and/or scaling the innovation | *This question can be skipped if there are currently no bilateral projects contributing *Only provide details of bilateral projects that are active and currently contribution (past contributions/funders can be acknowledged in section 5) | ||||||||||||||||||||||||
30 | Contributing Centers: Select the primary and contributing CGIAR centres * | |||||||||||||||||||||||||
31 | Theory of Change: Does this result match a planned result in your Initiative Theory of Change (ToC)?* | Yes/ No (see next rows) | *People can access the Initiative Theory of Change through the PRMS portal | |||||||||||||||||||||||
32 | If yes | Specify to which Work Package or End of Initiative outcomes the scaling of the core innovation is expected to contribute to by 2024 in the specific geolocation | ||||||||||||||||||||||||
33 | If no | Which End of Initiative outcome does it link to most closely? | ||||||||||||||||||||||||
34 | Do you want to review relations with AA Outcomes, IA, SDG and related Targets defined in your TOC for this result? | Yes, validate the AA outcome, Impact Area and Sustainable Development Goal mapping below No, continue to "Section 3: Partners" | * Validating the AA Outcomes, IA and SDG mapping may be important for Results that were not planned in the original Initiative ToC | |||||||||||||||||||||||
35 | If yes | Validate Action Area Outcome mapping: Indicate/ validate to which CGIAR Action Area Outcome(s) the innovation is expected to contribute by end of 2030 | *Select only the AA outcomes to which the Innovation is expected to make a significant and/or quantifiable contribution by end 2030 | |||||||||||||||||||||||
36 | If yes | Validate Impact Area Target(s) mapping: Indicate/ validate to which CGIAR Impact Area(s) and related Collective Global Target(s) the innovation is expected to contribute by end of 2030 | *Select only the Impact Area(s) and related Collective Global 2030 Target(s) to which the Innovation is expected to make a significant and/or quantifiable contribution by end 2030 | CGIAR Impact Areas and Targets | ||||||||||||||||||||||
37 | If yes | Validate Sustainable Development Goal Target(s) mapping: Indicate to which SDG(s) and SDG Target(s) the Innovation is expected to contribute by 2030 | *Innovations can be at different maturity of readiness level. This question seeks to capture the impact that this innovation could contribute to when proven to work and used at scale. *Select only those SDG(s) and SDG(s) Targets to which the innovation is expected to make a significant contribution. | SDGs and SDG Targets | ||||||||||||||||||||||
38 | Section 3: Partners | |||||||||||||||||||||||||
39 | Partners: Provide the names of partner organizations who are currently contributing to innovation development,testing and/or scaling | *If partners are not in the list, they can be added to the list *For each partner added you can indicate whether this is a Scaling, Demand or Innovation partner | ||||||||||||||||||||||||
40 | Partner role: Specify for each partner whether they are demand, innovation or scaling partners. Multiple roles can be selected. | *There is an other option if demand, innovation or scaling partner does not reflect the partner role | ||||||||||||||||||||||||
41 | Section 4: Geographic location | |||||||||||||||||||||||||
42 | What is the main geographic focus of the Output?: What is the most appropriate geolevel where the innovation is currently or expected to contribute to outcomes and impact? * - Global (option to also specify regions and countries) - Regional (select region(s) and option to also specify countries) - National (select specific countries) - Subnational (select subnational units) - This is yet to be determined | *If the innovation is not yet being developed, tested and/or scaled anywhere, then choose answer option: ‘This is yet to be determined’ *More detail is better, so try to geotag the innovation at country-level before considering regional or global tagging. | ||||||||||||||||||||||||
43 | Section 5: Links to results | |||||||||||||||||||||||||
44 | Did another result type contribute to this result?: | *Search the database for any related results (e.g. reported knowledge products such as science articles) | ||||||||||||||||||||||||
45 | Results from previous portfolio: Was this Innovation developed under CGIAR Research Programs (CRPs) and/ or Projects and has it been documented in the CGIAR Innovation Dashboard? | *Guidance on how to retrieve the innovation URL can be found here: https://cgiar.sharepoint.com/:b:/s/ScalingReadiness/ESnzThAALolIrSwH95WSHAoBYiqsOM7DLXLSlyw4szpwWg?e=QFVg9L | CGIAR Innovation Dashboard | |||||||||||||||||||||||
46 | Section 6: Innovation Development | |||||||||||||||||||||||||
47 | Provide a short name for the innovation (max 10 words)* | * Innovations are new, improved, or adapted technologies or products, capacity development tools and services, and policies or institutional arrangements with high potential to contribute to positive impacts when used at scale. - Innovations may be at early stages of readiness (ideation and upstream research) or at more mature stages of readiness (delivery and scaling) * Try to think of a short name that facilitates clear communication about the innovation. * Avoid abbreviations or (technical) jargon. * If not essential, avoid making reference to specific countries or regions (this is captured through geotagging) * Avoid the use of CGIAR centre, Initiative or organization names in the short title * Varieties or breeds should be described by their generic traits or characteristics (e.g. Drought tolerant and aphid resistant groundnut cultivars). The specific number of new or improved lines/ varieties can be specified elsewhere | ||||||||||||||||||||||||
48 | What would be the best way to characterize this innovation? * - Incremental innovation: Innovations that already exist and undergo constant, steady progress and improvement. - Radical innovation: Innovations that are new and replace existing products, systems, services and/or policies but do not cause or require major reconfiguration of farming, market and/or policy/ business models. - Disruptive innovation: Innovations that are new and cause or require major reconfiguration of farming, market and/or policy/ business models. - Other/ I’m not sure/ This characterization does not work for my innovation | Mark with an X below | *Choose ‘other’ if you feel the Innovation does not fit well with the proposed answers or if you are not sure which answer to select | |||||||||||||||||||||||
49 | Which of the below typologies best fits the nature of the innovation?* - Technological innovation: Innovations of technical/ material nature, including varieties/ breeds; crop and livestock management practices; machines; processing technologies; big data and information systems. > If yes, are you profiling a new or improved variety or breed? >If yes, specify the please indicate the number of individual new or improved lines/ varieties. - Capacity development innovation: Innovations that strengthen capacity, including farmer, extension or investor decision-support services; accelerator/ incubator programs; manuals, training programs and curricula; online courses. - Policy, organizational or institutional innovation: Innovations that create enabling conditions, including policy, legal and regulatory frameworks; business models; finance mechanisms; partnership models; public/ private delivery strategies. - Other/ I’m not sure/ This typology does not work for my innovation | *Choose ‘other’ if you feel the Innovation does not fit well with the proposed typologies or categories. | ||||||||||||||||||||||||
50 | Anticipated Innovation User: Who would be the anticipated user(s) of this innovation?* | *Depending on the innovation, users may be groups of actors or be organizations. *Multiple actors or organizations can be selected | ||||||||||||||||||||||||
51 | Actor | Farmers/ (agro)pastoralist/ herders/ fishers | Yes/No | *Multiple actor groups can be selected *For each actor group, please specify whether specifically women and/or youth are targeted *Multiple "other" actor groups can be added if needed | ||||||||||||||||||||||
52 | Specifically Women? | Yes/No | ||||||||||||||||||||||||
53 | Specifically Youth? | Yes/No | ||||||||||||||||||||||||
54 | Researchers | Yes/No | ||||||||||||||||||||||||
55 | Specifically Women? | Yes/No | ||||||||||||||||||||||||
56 | Specifically Youth? | Yes/No | ||||||||||||||||||||||||
57 | Extension Agents | Yes/No | ||||||||||||||||||||||||
58 | Specifically Women? | Yes/No | ||||||||||||||||||||||||
59 | Specifically Youth? | Yes/No | ||||||||||||||||||||||||
60 | Policy actors | Yes/No | ||||||||||||||||||||||||
61 | Specifically Women? | Yes/No | ||||||||||||||||||||||||
62 | Specifically Youth? | Yes/No | ||||||||||||||||||||||||
63 | Other: ___________________ | Yes/No | ||||||||||||||||||||||||
64 | Specifically Women? | Yes/No | ||||||||||||||||||||||||
65 | Specifically Youth? | Yes/No | ||||||||||||||||||||||||
66 | Org | Organization type 1 | *Select from drop down list | Detailed overview of the CGIAR organization typology can be found here | ||||||||||||||||||||||
67 | Organization type 2 | |||||||||||||||||||||||||
68 | Add rows if needed | |||||||||||||||||||||||||
69 | Other | Specify if appropriate | *Could be hectares, projects, other | |||||||||||||||||||||||
70 | Responsible innovation (GESI): Have concrete actions been taken to understand and improve Gender Equality and Social Inclusivity (GESI) in developing this innovation? * | >Yes, the following actions have been taken: (only upon selecting yes, offer below answer options from which multiple can be selected) *Dedicated CGIAR GESI expert on innovation development team *Dedicated partner(s) with GESI expertise in innovation development team *Engaging diverse innovation use groups in innovation development *Commissioned a GESI study, or context analysis *Used GESI-tools (e.g. GenderUp,) *Other __________________________________ >No actions taken yet >No Gender Equality and Social Inclusivity issues expected >It is too early to determine this | ||||||||||||||||||||||||
71 | Responsible innovation (unintended consequences): Have concrete actions been taken to understand and/or limit potential unintended negative consequences or impacts if the innovation is used at scale? * | >Yes, the following actions have been taken: only upon selecting yes, offer below answer options from which multiple can be selected) *Dedicated CGIAR expert on innovation development team *Dedicated partner(s) with expertise in innovation development team *Engaging diverse innovation use groups in innovation development *Commissioned impact studies, or context analysis *Used tools to anticipate unexpected negative impacts *Other __________________________________ >No actions taken yet >No negative consequences or impacts expected >It is too early to determine this | Think about how innovation use at scale may lead to: *Increased greenhouse gas emissions; *Losses in (agro-)biodiversity; *Gender inequality and/or social exclusion; *Compromised human health, nutrition and/or food security; *Increase income gaps or (youth) unemployment. | |||||||||||||||||||||||
72 | Intellectual Property Rights: Do you expect private sector engagement in innovation development and/or scaling? | >Yes (go to next) >Not sure (go to next) >No (go to INNOVATION DEVELOPER question) | ||||||||||||||||||||||||
73 | If yes/ not sure | Do you consider applying for formal Intellectual Property Rights? | >Yes (go to next) >Not sure (go to next) >No (go to INNOVATION DEVELOPER question) | More information on what is Intellectual Property here: https://www.wipo.int/about-ip/en/ | ||||||||||||||||||||||
74 | If yes/ not sure | Would you like to receive support from a "Private Partnership for Impact" expert? | >Yes, please contact me >No, not now | *Support can include expertise in Intellectual Property management, and/or the development of value propositions and business models, and/or support in negotiations with private partners | ||||||||||||||||||||||
75 | Innovation Developer: Provide the full name and email address, and organizational affiliation(s) of the innovation developer/ contact person * | *Innovation developer/ contact person will be first author of the Innovation Profile document. * Innovation developer/ contact person will be the prime contact for the innovation. | ||||||||||||||||||||||||
76 | Innovation Collaborators: Provide the full names of other key CGIAR and/or partner colleagues that contribute to this innovation | *Names of key contributors will feature as co-authors on the Innovation Profile document in the same order as provided below. *Email addresses are optional | ||||||||||||||||||||||||
77 | Innovation Team Composition: Have concrete actions been taken to promote diversity in the composition of the CGIAR and partner innovation team? * | >Yes, concrete actions have been taken to ensure (only upon selecting yes, offer below answer options from which multiple can be selected): *Gender diversity *Diversity in years of experience (e.g. early-career, mid-career, late-career) *Diversity in expertise (e.g. science expertise, development expertise, expertise of innovation users/ clients, other) *Disciplinary diversity (e.g. breeding, agronomy, economics, policy, sociology, anthropology, environmental sciences, other) *Regional diversity (Southeast Asia and the Pacific, East and Southern Africa, Central and West Asia and North Africa, South Asia, West and Central Africa, Latin America and the Caribbean, United-States/Canada, Europe, Australia) *Other: _______________________ >No concrete actions to diversify the innovation team composition have been taken >This does not apply to this innovation | *Diversity is known to affect innovation development processes. Maximizing team diversity is not always relevant, and the desired level of diversity may depend on the innovation, the context and readiness level of the innovation. | |||||||||||||||||||||||
78 | How would you assess the current readiness of this innovation?* Level 9 - The innovation is validated for its ability to achieve a specific impact under uncontrolled conditions. Level 8 - The innovation is being tested for its ability to achieve a specific impact under uncontrolled conditions. Level 7 - The innovation is validated for its ability to achieve a specific impact under semi-controlled conditions. Level 6 - The innovation is being tested for its ability to achieve a specific impact under semi-controlled conditions. Level 5 - The innovation is validated for its ability to achieve a specific impact under fully controlled conditions. Level 4 - The innovation is being tested for its ability to achieve a specific impact under fully controlled conditions. Level 3 - The innovation’s key concepts have been validated for their ability to achieve a specific impact. Level 2 - The innovation’s key concepts are being formulated or designed. Level 1 - The innovation’s basic principles are being researched for their ability to achieve a specific impact. Level 0 - The innovation is at idea stage. | *At this point we provide a single readiness score to the innovation, irrespectively of the specific geo-location where the innovation is being designed, tested and/or scaled. Geo-location-specific scoring will be part of innovation packaging and scaling readiness assessment. *Be realistic in assessing the readiness level of the innovation and keep in mind that the claimed readiness level needs to be supported by evidence documentation. | YOUR READINESS SCORE IN JUST 3 CLICKS... TRY THE NEW INNOVATION READINESS CALCULATOR: https://www.scalingreadiness.org/calculator-readiness-headless/ | |||||||||||||||||||||||
79 | Innovation Readiness Infrographic | |||||||||||||||||||||||||
80 | Provide a brief explanation that explains how the provided evidence/ documentation (URL provided under Section 7) justifies the chosen innovation readiness level (max 50 words)* | *Example: “We chose innovation readiness level 6 (semi-controlled testing) for the genetically improved farm tilapia (GIFT) because it is currently being tested under semi-controlled conditions in the multiplication center and hatchery in the selected countries as shown in the provided evidence.” | ||||||||||||||||||||||||
81 | Estimated USD investment (in-kind + in-cash) during the reporting period by: | |||||||||||||||||||||||||
82 | Lead Initiative | *Innovation development team estimates the total 2022 investment (in-cash/ in-kind) in innovation development *Includes Initiative funds allocated to CGIAR and/or partners | ||||||||||||||||||||||||
83 | Contributing Initiatives(s) | INIT-X Name: USD ____________ | *Innovation development team works together with Contributing Initiatives (Section 2) to estimate their total 2023 (co-)investment (in-cash/ in-kind) in innovation development *Includes Initiative funds allocated to CGIAR and/or partners | |||||||||||||||||||||||
84 | INIT-Y Name: USD ____________ | |||||||||||||||||||||||||
85 | Add rows if needed | |||||||||||||||||||||||||
86 | Bilateral Project(s) | Project Name A: USD ____________ | *Innovation development team works together with bilateral project teams (Section 2) to estimate their total 2023 (co-)investment (in-cash/ in-kind) in innovation development *Includes W3/Bilateral funds allocated to CGIAR and/or partners | |||||||||||||||||||||||
87 | Project Name B: USD ____________ | |||||||||||||||||||||||||
88 | Add rows if needed | |||||||||||||||||||||||||
89 | Partner co-investment | Partner Name 1: USD ____________ | *Innovation development team works together with partners (Section 2) to estimate their total 2023 (co-)investment (in-cash/ in-kind) *This concerns the investment of partner resources (in-cash and/or in-kind) that were not provided by CGIAR Initiatives or projects | |||||||||||||||||||||||
90 | Partner Name 2: USD ____________ | |||||||||||||||||||||||||
91 | Add rows if needed | |||||||||||||||||||||||||
92 | Would you like this Innovation to be published as CGIAR IPSR Innovation Profile PDF that will be made available in CG-space? | Yes (answer below acknowledgement and visual/ ref materials questions No (go to next Section) | Examples here: CGIAR IPSR Outputs | |||||||||||||||||||||||
93 | If yes | Innovation acknowledgement: Are there any specific investors or donors – other than the CGIAR Fund Donors https://www.cgiar.org/funders/ who provide core/pooled funding– that you wish to acknowledge for their critical contribution to the continued development, testing, and scaling of this Innovation ? | *Donors/ Investors will be included in the acknowledgment sections in the Innovation Profiles | CGIAR Funders | ||||||||||||||||||||||
94 | If yes | Visuals: Provide at least 1 URL to key images, photos or pictures that best represent or describe the innovation | *Provide URLs to high-resolution images, photos or pictures that clearly visualize the innovation (e.g., how it provides a specific solution to a problem, its use in practice, etc.) *The image(s) will be used in the final report of the survey, therefore consent to use the image(s) is needed. *Feel free to provide this information in a single folder and provide the link to that folder in the PRMS | |||||||||||||||||||||||
95 | If yes | Reference materials: Provide at least 1 URL to reference material(s) that describe the innovation | *Reference materials may include (science) publications, websites, newsletters, reports, newspaper articles, videos, etc. *Feel free to provide this information in a single folder and provide the link to that folder in the PRMS | |||||||||||||||||||||||
96 | Section 7: Evidence | |||||||||||||||||||||||||
97 | Innovation readiness evidence: Provide URL(s) to max 3 evidence/ documentation in support of the current innovation readiness level (that is chosen in the next Section 6) * | *There is an option to provide details of where evidence can be found within the source link (e.g. page number, slide number, table number) *Provide evidence/documentation in support of the current innovation readiness level (for level 0 no evidence needs to be provided) *Innovation Readiness level evidence may include idea-notes, concept-notes, technical report, pilot testing report, experimental data paper, newsletter, etc. It may be project reports, scientific publications, book chapters, communication materials that provide evidence of the current development/ maturity stage of the innovation. * For innovation readiness level 0, no evidence is required. If the PRMS prompts you to provide evidence, and you have chosen level 0, then feel free to provide any random URL. *Examples of evidence documentation for different CGIAR innovations and readiness levels can be found here | Innovation Readiness evidence examples | |||||||||||||||||||||||
98 | Gender/ climate/ nutrition/ environment/ poverty tag evidence: Provide URL(s) in support of the Tag 2 (if a tag of 2 is selected in Section 1)* | *Evidence is not required for tags 0 or 1. | ||||||||||||||||||||||||
99 | ||||||||||||||||||||||||||
100 |